about
The inhibition of the highly expressed miR-221 and miR-222 impairs the growth of prostate carcinoma xenografts in miceFhit interaction with ferredoxin reductase triggers generation of reactive oxygen species and apoptosis of cancer cellsExpression analysis of the gene encoding for the U-box-type ubiquitin ligase UBE4A in human tissuesmiR-24 triggers epidermal differentiation by controlling actin adhesion and cell migrationPhenotypic heterogeneity influences the behavior of rat aortic smooth muscle cells in collagen latticeModulation of clusterin isoforms is associated with all-trans retinoic acid-induced proliferative arrest and apoptosis of intimal smooth muscle cellsDifferential roles of p63 isoforms in epidermal development: selective genetic complementation in p63 null miceModulation of Ku70/80, clusterin/ApoJ isoforms and Bax expression in indocyanine-green-mediated photo-oxidative cell damage.Prenatal restraint stress generates two distinct behavioral and neurochemical profiles in male and female rats.Protein unlocking procedures of formalin-fixed paraffin-embedded tissues: application to MALDI-TOF imaging MS investigations.Microcalcifications in breast cancer: an active phenomenon mediated by epithelial cells with mesenchymal characteristics.Trastuzumab and docetaxel in a preclinical organotypic breast cancer model using tissue slices from mammary fat pad: Translational relevance.Radionuclide Therapy of Unresectable Tumors with AvidinOX and (90)Y-biotinDOTA: Tongue Cancer Paradigm.Extracellular proteases in atherosclerosis and restenosis.Aging, smooth muscle cells and vascular pathobiology: implications for atherosclerosis.Carnitine palmitoyl transferase-1A (CPT1A): a new tumor specific target in human breast cancer.CX3CR1 receptor polymorphisms, Th1 cell recruitment, and acute myocardial infarction outcome: looking for a link.CLU and colon cancer. The dual face of CLU: from normal to malignant phenotype.CLU "in and out": looking for a link.Transglutaminase 2 as a biomarker of osteoarthritis: an update.Induction and regulation of Smad7 in the gastric mucosa of patients with Helicobacter pylori infection.Experimental hypercholesterolemia induces ultrastructural changes in the internal elastic lamina of porcine coronary arteries.MiR-203 controls proliferation, migration and invasive potential of prostate cancer cell lines.Protease-activated receptor-2 activation in gastric cancer cells promotes epidermal growth factor receptor trans-activation and proliferation.Characterisation of a human glioblastoma cell line (LI) expressing hypothalamic and pituitary hormones.Topical treatment of basal cell carcinoma with tazarotene: a clinicopathological study on a large series of cases.Cardiac sarcomas: an update.Symptomatic laryngeal nodular chondrometaplasia: a clinicopathological study.Propionyl-L-carnitine improves postischemic blood flow recovery and arteriogenetic revascularization and reduces endothelial NADPH-oxidase 4-mediated superoxide production.A pathobiologic link between risk factors profile and morphological markers of carotid instability.Propionyl-L-carnitine reduces intimal hyperplasia after injury in normocholesterolemic rabbit carotid artery by modulating proliferation and caspase 3-dependent apoptosis of vascular smooth muscle cells.High-resolution multicontrast-weighted MR imaging from human carotid endarterectomy specimens to assess carotid plaque components.Prevalence and genotyping of human papillomavirus infection in women with vulvodynia.Clusterin in stool: a new biomarker for colon cancer screening?Lead brachial neuropathy in heroin addiction. A case report.Modulation of different clusterin isoforms in human colon tumorigenesis.Sphingosine 1-phosphate induces antimicrobial activity both in vitro and in vivo.Intracerebral fibroma: light and electron microscopic study.Cellular retinol-binding protein-1 expression in endometrial stromal cells: physiopathological and diagnostic implications.Comparative clinicopathologic and immunohistochemical analysis of uterine sarcomas diagnosed using the World Health Organization classification system.
P50
Q21562496-6A13BC24-5C89-49B8-81B8-04478D5B66E2Q24321254-30C4BBA6-BFA4-4B82-860F-CB1FC8376CD8Q28250301-68223753-B180-40E9-9E29-5F2AA56265F0Q28277153-BA1EBBA6-AA0A-4BED-8CB5-BF8CABA40917Q28573060-E3104643-AE0A-4F12-82D7-B8E5CE59842FQ28575645-4A6F3999-8830-49E9-8FB1-C121C2495960Q28589270-102C9FFD-2EEB-4E16-B92C-8A7A81E72C7CQ33286023-DC65B22C-D03E-41BF-8C2D-C71B35CAAE6AQ33334413-1BB9A8A0-E952-4593-A19F-28D6001D8EECQ33360328-624DAA2D-F769-4CCE-A51A-71F8336B6FEDQ33612598-3F829022-4B89-4EE3-91BC-19A43D31CBEEQ35934478-7BC7F4FB-A73C-4585-AF80-DE5C3F9826AAQ36074100-F813D786-D3D6-4556-B7BB-E11F641E2E4EQ36085385-407CF11F-3D00-43A5-B28E-79D7CC33D2C6Q36400028-D8DB59CB-BD87-41C6-909D-0C2196B0A77EQ37190231-C4D31C5E-2DAE-4054-A641-4D8E5B256F38Q37338290-24A8DE2B-AB3E-4426-A815-81D2FDEE25C3Q37625183-B4E7F84D-564E-4FDC-B6F5-9E249B1F5AC9Q37625191-B0D06492-EAE5-4A41-BBAE-035AECAA416FQ37964507-9B7FBBE1-CBC3-442F-B114-38611636D676Q38344292-65BABF6E-E10C-4E07-8090-020615FCD32EQ39473789-6777D85B-F2D5-469E-AE27-5027B4856D15Q39582762-9AA39152-1EDD-42C2-82F9-21D50EF05FEFQ40260379-254FE74B-9214-4BCA-B179-636394D24C0DQ41645467-1778DE94-D259-4A4D-8C6E-530CA3377314Q42465127-7267C734-2159-4125-AA99-F98CB6E7D154Q42961785-58771D90-4B39-433D-9D8B-C1A1AC87BF0FQ43010899-8DFB9DBA-9BE3-4768-83D2-9B4223CA13E6Q43199839-0F66DCC1-3E22-47FF-9D86-B17A42B12E27Q43291433-F4AEEDE3-B55C-4FBA-AB70-AC312F19F838Q43833274-FE10C8DE-7047-4963-9D93-3B242ABD7078Q43924483-F5BE1CED-2C9B-4019-845C-3CB9F8DBB317Q44026999-82051685-BEFF-4FF1-8426-E4F09D3B6D1DQ44117904-110A0387-9F7D-448E-8D72-0E036D0F382DQ44492797-5A6B0D2D-B9F5-466B-906A-5B31768401E5Q44750584-02518C0A-512D-480D-94AF-0DFB3026B644Q44896089-B2A80177-5FEE-4AAE-9956-182729C5AA74Q45065409-F0ABF62B-C588-40AD-BBDF-D785E3518F0BQ45120873-F71ACDE8-613D-4B7A-87D3-FFD9E4064F76Q45961644-6CCB312A-697E-4C8A-8D75-B131EFD02BFC
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Luigi Giusto Spagnoli
@ast
Luigi Giusto Spagnoli
@en
Luigi Giusto Spagnoli
@es
Luigi Giusto Spagnoli
@sl
type
label
Luigi Giusto Spagnoli
@ast
Luigi Giusto Spagnoli
@en
Luigi Giusto Spagnoli
@es
Luigi Giusto Spagnoli
@sl
prefLabel
Luigi Giusto Spagnoli
@ast
Luigi Giusto Spagnoli
@en
Luigi Giusto Spagnoli
@es
Luigi Giusto Spagnoli
@sl
P106
P1153
7004972444
P21
P31
P496
0000-0002-0684-5501